The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
we developed a technique to introduce these anti cd19 car molecules chimeric antigen receptors into te- cells to create a car t- cell that when we administered to patients would kill every cell in the body that expressed cd19 so all the normal B cell cells were eliminated but so too were lymphomas and leukemias
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
it turns out there's a molecule on B lymphocytes called cd19 we don't exactly know what its function is but when B cells turn into lymphomas and Leukemia they continue to express cd19
Whole-body MRI screening in healthy adults produces more incidentaloma harm than cancer-mortality benefit.
Starting colonoscopy screening at 45 (vs 50) prevents enough early-onset cancers to justify the population cost.
Multi-cancer liquid-biopsy tests like Galleri detect early cancers at a stage that meaningfully improves survival.